Course Content

Company Formation: Assessment Questions

Course Overview

Needs and Markets

Intellectual Property

Regulatory and Reimbursement

• Company Formation

Video
Slides
Questions
Example
Worksheet

Funding

Financials

Summary

Provide FEEDBACK

Answer the following questions regarding the important topics covered in this section of the CD. The correct answers can be accessed through the link at the bottom of the page.

1. In most medical-technology companies, an early clinical trial is necessary to validate the company's core technology. Which of these is the most important aspect of that trial?
   1. Its ability to enhance your company's knowledge of the target market
   2. The number of patients enrolled
   3. The prestige of the medical centers conducting the trial
   4. Its exposure in the press
2. Which of the following is the most critical element determining a company's success or failure, according to Hank Plain?
   1. Clinical results
   2. Estimation of the market opportunity outside the US
   3. Technical innovation
   4. The competence and composition of the core team
3. Which of the following skills is least necessary in an early-stage company's core team?
   1. Technical expertise
   2. Expertise in IP law
   3. Clinical expertise
   4. Management expertise
4. Which is important to consider when selecting a team of clinical advisors?
   1. Enlisting clinicians who see a relatively high volume of potential candidates for your product
   2. Enlisting physicians who will collect clinical data without complicating matters by providing feedback or technical suggestions
   3. Enlisting physicians who are accustomed to working independently or with few colleagues
   4. Both A and B
5. What is the most effective way of making reimbursement decisions in an early-stage medical technology company?
   1. Assign this responsibility to the management team
   2. Hire a contract reimbursement consultant
   3. Hire a full-time reimbursement expert
   4. Addressing reimbursement issues is relatively unimportant in a company's early stages